CCRM turns 10: What does this mean for cell and gene therapy in Canada?
CCRM signs agreements with Canadian and international institutions to advance regenerative medicine inventions
CCRM and Amgen partner to advance emerging medical innovations
McGill to partner with CCRM in commercializing regenerative medicine
CCRM and McMaster Innovation Park (MIP) Partner to Build and Operate Biomanufacturing Campus
Innovation Economy Council releases white paper — Factory Forward: How Advanced Manufacturing is Retooling Ontario’s Industrial
New iPSC master cell banks to accelerate development of novel cell therapies
Innovation Economy Council formed to drive Canada’s technology economy post-pandemic
Toronto Centre solving cell manufacturing challenges to benefit patients and global industry
Avectas and CCRM Announce Collaboration To Accelerate Development of Novel Technology for Cell Therapies
